Join to View Full Profile
1515 Holcombe BlvdUnit 1445Houston, TX 77030
Phone+1 713-792-6528
Fax+1 713-794-4662
Dr. Lai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemResidency, Otolaryngology - Head and Neck Surgery, 1999 - 2003
University of California San Francisco School of MedicineClass of 1998
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 1982 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2008 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology- Join now to see all
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
- Join now to see all
Clinical Trials
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients with Head and Neck Cancer That is Primary, Has Come Back, or Has Spread to Other Places in the Body Start of enrollment: 2017 Mar 21
- Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients with Oral Cavity or Skull Base Tumors Start of enrollment: 2018 Sep 17
- An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy Start of enrollment: 2020 Aug 12
Publications & Presentations
PubMed
- International multispecialty expert physician preoperative identification of extranodal extension in patients with oropharyngeal cancer using computed tomography: Pros...Onur Sahin, Serageldin Kamel, Kareem A Wahid, Cem Dede, Nicolette Taku
Cancer. 2025-04-01 - Evaluating observer reliability and diagnostic accuracy of CT-LEFAT criteria for post-treatment head and neck lymphedema: A prospective blinded comparative analysis.Natalie A West, Serageldin K Attia, Zaphanlene Kaffey, Cem Dede, Samuel L Mulder
Oral Oncology. 2025-04-01 - Cross-Cultural Adaptation and Translation of the Neck Dissection Impairment Index (NDII) into Spanish.Lismelia Vargas, Jake Langlie, Christie McGee, Ruixuan Ma, Olivia Perdigon
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale. 2025-03-12
Journal Articles
- Risk and Clinical Risk Factors Associated with Late Lower Cranial Neuropathy in Long-Term Oropharyngeal Squamous Cell Carcinoma SurvivorsRyan P Goepfert, Stephen Y Lai, Renata Ferrarotto, Erich M Sturgis, JAMA Otolaryngology–Head & Neck Surgery
- Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaJanice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
- Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaScott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
- Join now to see all
Press Mentions
Sentinel Lymph Node Biopsy: What Cancer Patients Should KnowAugust 8th, 2024
Grant Support
- OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORshipUNIVERSITY OF TX MD ANDERSON CAN CTR2024–2029
- OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORshipUNIVERSITY OF TX MD ANDERSON CAN CTR2024–2029
- OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORshipUNIVERSITY OF TX MD ANDERSON CAN CTR2024–2029
- OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORshipUNIVERSITY OF TX MD ANDERSON CAN CTR2024–2029
- Development of miR-27a* for the Treatment of Head and Neck Squamous Cell CarcinomaUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
- Development of miR-27a* for the Treatment of Head and Neck Squamous Cell CarcinomaUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
- Development of miR-27a* for the Treatment of Head and Neck Squamous Cell CarcinomaUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
- Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)UNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
- Development of miR-27a* for the Treatment of Head and Neck Squamous Cell CarcinomaUNIVERSITY OF TX MD ANDERSON CAN CTR2023–2028
- Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2028
- Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2028
- Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2028
- Leveraging Hyperpolarized MRI for Precision Oncology Approaches in Head and Neck CancerUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2028
- Image Guided Cancer Therapy Training ProgramUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2027
- Radiosensitization of thyroid cancer by cancer cell specific reduction of gold ionsUNIVERSITY OF TX MD ANDERSON CAN CTR2022–2025
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
